Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39047

DNAH5 Knockout K562 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Pleural effusion

  • Disease:

    Chronic myeloid leukemia

The DNAH5 Knockout K-562 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal K-562 cell population with disrupted DNAH5, encoding an outer dynein arm heavy chain critical for ciliary motility. Although K-562 leukemia cells lack cilia, this knockout model enables study of DNAH5 interactions with partners like DNAI1 and DNAI2 in a non-ciliated background. Ideal for functional genomics, primary ciliary dyskinesia research, and CRISPR validation, this product supports assays such as western blot, RT-qPCR, and immunofluorescence, facilitating dissection of DNAH5 networks involving FOXJ1, RFX3, and NOTCH signaling.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    K562

    Sex of Donor

    Female

    Derived From Site

    In situ; Pleural effusion

    Gene Name

    DNAH5

    Gene Identifier

    NCBI Gene ID 1767

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAH5 Knockout K-562 Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population derived from the K-562 chronic myeloid leukemia (CML) cell line. This pool of edited cells harbors targeted gene disruption of the DNAH5 locus, resulting in loss of DNAH5 protein expression. As a polyclonal population, it represents a heterogeneous mixture of cells with various editing outcomes, enabling robust and reproducible functional studies without clonal selection. The product is ideal for researchers investigating DNAH5-dependent mechanisms in a hematopoietic context.

K-562 is a widely used suspension cell line established from the pleural effusion of a 53-year-old female with CML in blast crisis. These cells are characterized by the Philadelphia chromosome, resulting in BCR-ABL1 fusion, and serve as a model for studying leukemia biology and drug responses. Notably, K-562 cells lack ciliated phenotypes, making them a unique host for exploring DNAH5 functions independent of ciliary assembly. The host cell??s genetic background provides a clean system to dissect DNAH5 molecular interactions without confounding ciliary motility effects.

DNAH5 encodes an axonemal dynein heavy chain that constitutes a critical component of the outer dynein arm (ODA) in motile cilia. In ciliated cells, DNAH5 interacts with DNAI1, DNAI2, DNAL1, and TXNDC3 to assemble functional ODA complexes, driving ciliary beat and mucociliary clearance. Transcription of DNAH5 is regulated by FOXJ1 and RFX3, key transcription factors for motile ciliogenesis, and is modulated by NOTCH signaling. Disruption of DNAH5 abrogates ODA motor activity, leading to immotile cilia and impaired airway surface liquid homeostasis, hallmarks of primary ciliary dyskinesia (PCD).

While K-562 cells do not form cilia, the knockout model remains valuable for investigating DNAH5 protein stability, binding partners, and potential non-ciliary functions. The loss of DNAH5 in this leukemic background permits examination of how ODA components behave in the absence of functional axonemes and allows mapping of interaction networks among DNAH5 and its interacting factors without interference from ciliary dynamics. This system can also be used to screen modulators of DNAH5 expression or to study the impact of DNAH5 deficiency on cellular signaling pathways.

This DNAH5 knockout cell pool supports a wide array of research applications, including functional genomics of ciliary motility, validation of CRISPR guide RNA efficiency, and mechanistic studies of PCD. Researchers can employ assays such as western blotting and RT-qPCR to confirm DNAH5 ablation, genomic DNA PCR and T7E1 mismatch detection to assess editing frequency, and immunofluorescence or co-immunoprecipitation to probe protein interactions. For further technical inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)